Back to Explorer

21CFR211.63

§ 211.63 Equipment design, size, and location.

17 citations

Regulation Text

Equipment used in the manufacture, processing, packing, or holding of a drug product shall be of appropriate design, adequate size, and suitably located to facilitate operations for its intended use and for its cleaning and maintenance.

Authority

21 U.S.C. 321,351,352,355,360b,360ddd,360ddd-1,371,374;42 U.S.C. 216,262,263a,264.

View in Graph Explorer

Related Warning Letters (10)

  • CGMP/Finished Pharmaceuticals/Adulterated

    SV Labs Corporation

    2025-12-23

  • CGMP/Finished Pharmaceuticals/Adulterated

    World Perfumes Inc.

    2025-11-18

  • CGMP/Finished Pharmaceuticals/Adulterated

    Liebel-Flarsheim Company LLC

    2025-11-04

  • CGMP/Finished Pharmaceuticals/Adulterated

    BRS Analytical Services, LLC

    2025-10-21

  • CGMP/Finished Pharmaceuticals/Adulterated

    Yiling Pharmaceutical Ltd.

    2025-06-03

  • CGMP/Finished Pharmaceuticals/Unapproved New Drug/Adulterated

    Aqualex Co., Ltd.

    2024-06-18

  • CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

    Sun Pharmaceutical Industries Ltd.

    2023-10-16

  • CGMP/Finished Pharmaceuticals/Adulterated

    Baxter Healthcare Corporation

    2023-08-01

  • CGMP/Finished Pharmaceuticals/Adulterated

    Profounda, Inc.

    2023-03-14

  • CGMP/Finished Pharmaceuticals/Adulterated

    Monarch PCM, LLC

    2022-06-28

Related Guidelines (4)